•  
  •  
  •  
  •  

2025-08-31 16:12:25

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Titan unveils 8 new brand outlets across Delhi NCR, strengthening their retail footprint with 1000+ stores in FY26
  • Zigly Unveils New Experience Centre at Phoenix Marketcity, Strengthens Mumbai Presence
  • XTGlobal Infotech Ltd and ICICI Bank Ltd enter into loan agreement
  • NCC Limited receives orders worth Rs. 788.34 crore
  • Thomas Cook India & SOTC Travel ink long-term strategic MOU with Queensland Tourism

Keywords Selected:  CaplinPointLaboratories

Stock Report

  • Caplin Point Laboratories Ltd Q1 FY2026 consolidated net profit up at Rs. 152.80 crores
  • Caplin Point Laboratories Limited declares interim dividend of Rs. 3
  • Caplin Point Laboratories Ltd Q4 FY2025 consolidated PAT climbs to Rs. 142.57 crores
  • Caplin Steriles Ltd receives USFDA final approval for ANDA Haloperidol Decanoate Injection
  • Caplin Steriles Ltd gets USFDA approval for Phytonadione Injectable Emulsion
  • Caplin Steriles Ltd receives USFDA final approval for ANDA Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution
  • Caplin Steriles gets USFDA approval for Levetiracetam in Sodium Chloride Injection, Infusion Bags
  • Caplin Steriles gets USFDA approval for Difluprednate Ophthalmic Emulsion
  • Caplin Point Laboratories Ltd's consolidated net profit for Q2FY25 higher at Rs. 130.80 crores
  • ANVISA - Brazil completes inspection at Caplin Steriles' facility at Gummidipoondi
  • Caplin Steriles Ltd gets USFDA approval for Ephedrine Sulfate injection USP
  • Caplin Point gets Colombia approval for Softgel Capsules
  • Caplin Steriles gets USFDA approval for Ofloxacin Ophthalmic Solution
  • Caplin Steriles gets USFDA approval for Ketorolac Tromethamine Ophthalmic Solution
  • Caplin Group successfully completes new Oncology facility, commences operations
  • Caplin Group announces Strategic Investment of INR 700 Crores in Tamil Nadu
  • Caplin Steriles Ltd gets USFDA approval for Ofloxacin OTIC Solution
  • Caplin Steriles gets USFDA approval for Norepinephrine Bitartrate Injection
  • Caplin Steriles receives EIR from US FDA
  • Caplin Point listed on Forbes Asia's '200 Best Under a Billion' for 2023
  • Caplin Steriles Ltd receives final approval from USFDA for ANDA Cisatracurium Besylate Injection USP
  • US FDA inspection completed at Caplin Steriles Injectable site at Gummidipoondi
  • Caplin Steriles gets USFDA approval for Ketorolac Tromethamine Injection
  • Caplin Steriles Ltd granted final approval by USFDA for Thiamine Hydrochloride Injection ANDA

Latest Post

  • Titan unveils 8 new brand outlets across Delhi NCR, strengthening their retail footprint with 1000+ stores in FY26
  • Zigly Unveils New Experience Centre at Phoenix Marketcity, Strengthens Mumbai Presence
  • XTGlobal Infotech Ltd and ICICI Bank Ltd enter into loan agreement
  • NCC Limited receives orders worth Rs. 788.34 crore
  • Thomas Cook India & SOTC Travel ink long-term strategic MOU with Queensland Tourism


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024